Nosocomial infections.
D000391:Air Microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000266:history / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D004927:Escherichia coli Infections / Q000453:epidemiology; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007275:Injections, Intravenous / Q000009:adverse effects; D007710:Klebsiella Infections / Q000453:epidemiology; D008171:Lung Diseases / Q000209:etiology; D009181:Mycoses / Q000453:epidemiology; D011183:Postoperative Complications / Q000453:epidemiology; D011512:Proteus Infections / Q000453:epidemiology; D011552:Pseudomonas Infections / Q000453:epidemiology; D014140:Tracheotomy / Q000009:adverse effects; D014481:United States; D014552:Urinary Tract Infections / Q000453:epidemiology
D000900:Anti-Bacterial Agents